Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 180


Foxo1 Promotes Th9 Cell Differentiation and Airway Allergy.

Buttrick TS, Wang W, Yung C, Trieu KG, Patel K, Khoury SJ, Ai X, Elyaman W.

Sci Rep. 2018 Jan 16;8(1):818. doi: 10.1038/s41598-018-19315-z.


Alternative diagnoses in patients referred to specialized centers for suspected MS.

Yamout BI, Khoury SJ, Ayyoubi N, Doumiati H, Fakhreddine M, Ahmed SF, Tamim H, Al-Hashel JY, Behbehani R, Alroughani R.

Mult Scler Relat Disord. 2017 Nov;18:85-89. doi: 10.1016/j.msard.2017.09.016. Epub 2017 Sep 21.


Rebound syndrome after teriflunomide cessation in a patient with multiple sclerosis.

Yamout BI, Said M, Hannoun S, Zeineddine M, Massouh J, Khoury SJ.

J Neurol Sci. 2017 Sep 15;380:79-81. doi: 10.1016/j.jns.2017.07.014. Epub 2017 Jul 9.


SUMMIT (Serially Unified Multicenter Multiple Sclerosis Investigation): creating a repository of deeply phenotyped contemporary multiple sclerosis cohorts.

Bove R, Chitnis T, Cree BA, Tintoré M, Naegelin Y, Uitdehaag BM, Kappos L, Khoury SJ, Montalban X, Hauser SL, Weiner HL; SUMMIT Consortium.

Mult Scler. 2017 Aug 1:1352458517726657. doi: 10.1177/1352458517726657. [Epub ahead of print]


Opposite functions of STAT3 and Smad3 in regulating Tiam1 expression in Th17 cells.

Buttrick T, Khoury SJ, Elyaman W.

Small GTPases. 2017 Jun 13:1-7. doi: 10.1080/21541248.2017.1341365. [Epub ahead of print]


Effect of vitamin D replacement on immunological biomarkers in patients with multiple sclerosis.

Mrad MF, El Ayoubi NK, Esmerian MO, Kazan JM, Khoury SJ.

Clin Immunol. 2017 Aug;181:9-15. doi: 10.1016/j.clim.2017.05.017. Epub 2017 May 20.


Defects in CD4+ T cell LFA-1 integrin-dependent adhesion and proliferation protect Cd47-/- mice from EAE.

Azcutia V, Bassil R, Herter JM, Engelbertsen D, Newton G, Autio A, Mayadas T, Lichtman AH, Khoury SJ, Parkos CA, Elyaman W, Luscinskas FW.

J Leukoc Biol. 2017 Feb;101(2):493-505. doi: 10.1189/jlb.3A1215-546RR. Epub 2016 Dec 13.


Th9 cells in the pathogenesis of EAE and multiple sclerosis.

Elyaman W, Khoury SJ.

Semin Immunopathol. 2017 Jan;39(1):79-87. doi: 10.1007/s00281-016-0604-y. Epub 2016 Nov 14. Review.


Blood Biomarkers as Outcome Measures in Inflammatory Neurologic Diseases.

El Ayoubi NK, Khoury SJ.

Neurotherapeutics. 2017 Jan;14(1):135-147. doi: 10.1007/s13311-016-0486-7. Review.


Tiam1/Rac1 complex controls Il17a transcription and autoimmunity.

Kurdi AT, Bassil R, Olah M, Wu C, Xiao S, Taga M, Frangieh M, Buttrick T, Orent W, Bradshaw EM, Khoury SJ, Elyaman W.

Nat Commun. 2016 Oct 11;7:13048. doi: 10.1038/ncomms13048.


Three cases of herpes zoster radiculitis in MS patients treated with natalizumab.

Yamout BI, Abou Zeid N, Taha AJ, Zeineddine MM, Khoury SJ.

Mult Scler Relat Disord. 2016 Sep;9:122-4. doi: 10.1016/j.msard.2016.07.012. Epub 2016 Jul 25.


Retinal measures correlate with cognitive and physical disability in early multiple sclerosis.

El Ayoubi NK, Ghassan S, Said M, Allam J, Darwish H, Khoury SJ.

J Neurol. 2016 Nov;263(11):2287-2295. Epub 2016 Aug 20.


ACCLAIM: A randomized trial of abatacept (CTLA4-Ig) for relapsing-remitting multiple sclerosis.

Khoury SJ, Rochon J, Ding L, Byron M, Ryker K, Tosta P, Gao W, Freedman MS, Arnold DL, Sayre PH, Smilek DE; ACCLAIM Study Group.

Mult Scler. 2017 Apr;23(5):686-695. doi: 10.1177/1352458516662727. Epub 2016 Aug 5.


Imaging in multiple sclerosis: A new spin on lesions.

Bou Fakhredin R, Saade C, Kerek R, El-Jamal L, Khoury SJ, El-Merhi F.

J Med Imaging Radiat Oncol. 2016 Oct;60(5):577-586. doi: 10.1111/1754-9485.12498. Epub 2016 Jul 27. Review.


Medical Research Volunteer Program (MRVP): innovative program promoting undergraduate research in the medical field.

Dagher MM, Atieh JA, Soubra MK, Khoury SJ, Tamim H, Kaafarani BR.

BMC Med Educ. 2016 Jun 6;16:160. doi: 10.1186/s12909-016-0670-9.


Comparative effect of 25(OH)D3 and 1,25(OH)2D3 on Th17 cell differentiation.

Fawaz L, Mrad MF, Kazan JM, Sayegh S, Akika R, Khoury SJ.

Clin Immunol. 2016 May;166-167:59-71. doi: 10.1016/j.clim.2016.02.011. Epub 2016 Apr 1.


JC virus seroprevalence and seroconversion in multiple sclerosis cohort: A Middle-Eastern study.

Alroughani R, Akhtar S, Ahmed SF, Khoury SJ, Al-Hashel JY, Sahraian MA, Al Jumah M, Zeineddine M, Farhat S, Doumiati H, Yamout BI.

J Neurol Sci. 2016 Jan 15;360:61-5. doi: 10.1016/j.jns.2015.11.044. Epub 2015 Nov 24.


Safety and efficacy of fingolimod in clinical practice: The experience of an academic center in the Middle East.

Yamout BI, Zeineddine MM, Tamim H, Khoury SJ.

J Neuroimmunol. 2015 Dec 15;289:93-7. doi: 10.1016/j.jneuroim.2015.10.015. Epub 2015 Oct 26.


Rheumatoid arthritis-associated RBPJ polymorphism alters memory CD4+ T cells.

Orent W, Mchenry AR, Rao DA, White C, Klein HU, Bassil R, Srivastava G, Replogle JM, Raj T, Frangieh M, Cimpean M, Cuerdon N, Chibnik L, Khoury SJ, Karlson EW, Brenner MB, De Jager P, Bradshaw EM, Elyaman W.

Hum Mol Genet. 2016 Jan 15;25(2):404-17. doi: 10.1093/hmg/ddv474. Epub 2015 Nov 24.


Serum 25-hydroxyvitamin D predicts cognitive performance in adults.

Darwish H, Zeinoun P, Ghusn H, Khoury B, Tamim H, Khoury SJ.

Neuropsychiatr Dis Treat. 2015 Aug 25;11:2217-23. doi: 10.2147/NDT.S87014. eCollection 2015.


Safety and efficacy of reduced fingolimod dosage treatment.

Yamout BI, Zeineddine MM, Sawaya RA, Khoury SJ.

J Neuroimmunol. 2015 Aug 15;285:13-5. doi: 10.1016/j.jneuroim.2015.05.012. Epub 2015 May 15.


Cell surface glycan engineering of neural stem cells augments neurotropism and improves recovery in a murine model of multiple sclerosis.

Merzaban JS, Imitola J, Starossom SC, Zhu B, Wang Y, Lee J, Ali AJ, Olah M, Abuelela AF, Khoury SJ, Sackstein R.

Glycobiology. 2015 Dec;25(12):1392-409. doi: 10.1093/glycob/cwv046. Epub 2015 Jul 7.


Risk factors for multiple sclerosis and associations with anti-EBV antibody titers.

Mouhieddine TH, Darwish H, Fawaz L, Yamout B, Tamim H, Khoury SJ.

Clin Immunol. 2015 May;158(1):59-66. doi: 10.1016/j.clim.2015.03.011. Epub 2015 Mar 21.


Effect of natalizumab treatment on circulating plasmacytoid dendritic cells: a cross-sectional observational study in patients with multiple sclerosis.

Kivisäkk P, Francois K, Mbianda J, Gandhi R, Weiner HL, Khoury SJ.

PLoS One. 2014 Jul 30;9(7):e103716. doi: 10.1371/journal.pone.0103716. eCollection 2014.


BCL6 controls Th9 cell development by repressing Il9 transcription.

Bassil R, Orent W, Olah M, Kurdi AT, Frangieh M, Buttrick T, Khoury SJ, Elyaman W.

J Immunol. 2014 Jul 1;193(1):198-207. doi: 10.4049/jimmunol.1303184. Epub 2014 May 30.


Clinical relevance and functional consequences of the TNFRSF1A multiple sclerosis locus.

Ottoboni L, Frohlich IY, Lee M, Healy BC, Keenan BT, Xia Z, Chitnis T, Guttmann CR, Khoury SJ, Weiner HL, Hafler DA, De Jager PL.

Neurology. 2013 Nov 26;81(22):1891-9. doi: 10.1212/01.wnl.0000436612.66328.8a. Epub 2013 Oct 30.


Sex influences in autoimmune disease.

Chitnis T, Khoury SJ.

Clin Immunol. 2013 Nov;149(2):169. doi: 10.1016/j.clim.2013.08.002. Epub 2013 Aug 9. No abstract available.


Evaluation of circulating osteopontin levels in an unselected cohort of patients with multiple sclerosis: relevance for biomarker development.

Kivisäkk P, Healy BC, Francois K, Gandhi R, Gholipour T, Egorova S, Sevdalinova V, Quintana F, Chitnis T, Weiner HL, Khoury SJ.

Mult Scler. 2014 Apr;20(4):438-44. doi: 10.1177/1352458513503052. Epub 2013 Sep 4.


IL-4 and retinoic acid synergistically induce regulatory dendritic cells expressing Aldh1a2.

Zhu B, Buttrick T, Bassil R, Zhu C, Olah M, Wu C, Xiao S, Orent W, Elyaman W, Khoury SJ.

J Immunol. 2013 Sep 15;191(6):3139-51. doi: 10.4049/jimmunol.1300329. Epub 2013 Aug 19.


Increased Th17 response to myelin peptides in pediatric MS.

Vargas-Lowy D, Kivisäkk P, Gandhi R, Raddassi K, Soltany P, Gorman MP, Khoury SJ, Chitnis T.

Clin Immunol. 2013 Mar;146(3):176-84. doi: 10.1016/j.clim.2012.12.008. Epub 2012 Dec 28.


An RNA profile identifies two subsets of multiple sclerosis patients differing in disease activity.

Ottoboni L, Keenan BT, Tamayo P, Kuchroo M, Mesirov JP, Buckle GJ, Khoury SJ, Hafler DA, Weiner HL, De Jager PL.

Sci Transl Med. 2012 Sep 26;4(153):153ra131.


In vitro and in vivo studies of IgG-derived Treg epitopes (Tregitopes): a promising new tool for tolerance induction and treatment of autoimmunity.

Cousens LP, Najafian N, Mingozzi F, Elyaman W, Mazer B, Moise L, Messitt TJ, Su Y, Sayegh M, High K, Khoury SJ, Scott DW, De Groot AS.

J Clin Immunol. 2013 Jan;33 Suppl 1:S43-9. doi: 10.1007/s10875-012-9762-4. Epub 2012 Sep 2. Review.


Galectin-1 deactivates classically activated microglia and protects from inflammation-induced neurodegeneration.

Starossom SC, Mascanfroni ID, Imitola J, Cao L, Raddassi K, Hernandez SF, Bassil R, Croci DO, Cerliani JP, Delacour D, Wang Y, Elyaman W, Khoury SJ, Rabinovich GA.

Immunity. 2012 Aug 24;37(2):249-63. doi: 10.1016/j.immuni.2012.05.023. Epub 2012 Aug 9.


Robust tumor immunity to melanoma mediated by interleukin-9-producing T cells.

Purwar R, Schlapbach C, Xiao S, Kang HS, Elyaman W, Jiang X, Jetten AM, Khoury SJ, Fuhlbrigge RC, Kuchroo VK, Clark RA, Kupper TS.

Nat Med. 2012 Aug;18(8):1248-53. doi: 10.1038/nm.2856. Epub 2012 Jul 8.


Notch receptors and Smad3 signaling cooperate in the induction of interleukin-9-producing T cells.

Elyaman W, Bassil R, Bradshaw EM, Orent W, Lahoud Y, Zhu B, Radtke F, Yagita H, Khoury SJ.

Immunity. 2012 Apr 20;36(4):623-34. doi: 10.1016/j.immuni.2012.01.020. Epub 2012 Apr 12.


The impact of lesion in-painting and registration methods on voxel-based morphometry in detecting regional cerebral gray matter atrophy in multiple sclerosis.

Ceccarelli A, Jackson JS, Tauhid S, Arora A, Gorky J, Dell'Oglio E, Bakshi A, Chitnis T, Khoury SJ, Weiner HL, Guttmann CR, Bakshi R, Neema M.

AJNR Am J Neuroradiol. 2012 Sep;33(8):1579-85. doi: 10.3174/ajnr.A3083. Epub 2012 Mar 29.


Type17 T-cells in central nervous system autoimmunity and tumors.

Okada H, Khoury SJ.

J Clin Immunol. 2012 Aug;32(4):802-8. doi: 10.1007/s10875-012-9686-z. Epub 2012 Mar 28. Review.


Immune modulation by Lacto-N-fucopentaose III in experimental autoimmune encephalomyelitis.

Zhu B, Trikudanathan S, Zozulya AL, Sandoval-Garcia C, Kennedy JK, Atochina O, Norberg T, Castagner B, Seeberger P, Fabry Z, Harn D, Khoury SJ, Guleria I.

Clin Immunol. 2012 Mar;142(3):351-61. doi: 10.1016/j.clim.2011.12.006. Epub 2011 Dec 30.


Magnetic resonance disease severity scale (MRDSS) for patients with multiple sclerosis: a longitudinal study.

Moodie J, Healy BC, Buckle GJ, Gauthier SA, Glanz BI, Arora A, Ceccarelli A, Tauhid S, Han XM, Venkataraman A, Chitnis T, Khoury SJ, Guttmann CR, Weiner HL, Neema M, Bakshi R.

J Neurol Sci. 2012 Apr 15;315(1-2):49-54. doi: 10.1016/j.jns.2011.11.040. Epub 2011 Dec 28.


Therapeutic strategies in multiple sclerosis.

Comabella M, Khoury SJ.

Clin Immunol. 2012 Jan;142(1):1. doi: 10.1016/j.clim.2011.11.008. Epub 2011 Dec 2. No abstract available.


Potential application of tregitopes as immunomodulating agents in multiple sclerosis.

Elyaman W, Khoury SJ, Scott DW, De Groot AS.

Neurol Res Int. 2011;2011:256460. doi: 10.1155/2011/256460. Epub 2011 Sep 15.


Plasticity of Ly-6C(hi) myeloid cells in T cell regulation.

Zhu B, Kennedy JK, Wang Y, Sandoval-Garcia C, Cao L, Xiao S, Wu C, Elyaman W, Khoury SJ.

J Immunol. 2011 Sep 1;187(5):2418-32. doi: 10.4049/jimmunol.1100403. Epub 2011 Aug 8.


Notch ligand delta-like 4 blockade alleviates experimental autoimmune encephalomyelitis by promoting regulatory T cell development.

Bassil R, Zhu B, Lahoud Y, Riella LV, Yagita H, Elyaman W, Khoury SJ.

J Immunol. 2011 Sep 1;187(5):2322-8. doi: 10.4049/jimmunol.1100725. Epub 2011 Aug 3.


Th17 and Treg balance in systemic sclerosis.

Khoury SJ.

Clin Immunol. 2011 Jun;139(3):231-2. doi: 10.1016/j.clim.2011.03.014. Epub 2011 Mar 22. No abstract available.


Immunopathogenesis of multiple sclerosis.

Comabella M, Khoury SJ.

Clin Immunol. 2012 Jan;142(1):2-8. doi: 10.1016/j.clim.2011.03.004. Epub 2011 Mar 12. Review.


The relationship between normal cerebral perfusion patterns and white matter lesion distribution in 1,249 patients with multiple sclerosis.

Holland CM, Charil A, Csapo I, Liptak Z, Ichise M, Khoury SJ, Bakshi R, Weiner HL, Guttmann CR.

J Neuroimaging. 2012 Apr;22(2):129-36. doi: 10.1111/j.1552-6569.2011.00585.x. Epub 2011 Mar 29.


One year activity on subtraction MRI predicts subsequent 4 year activity and progression in multiple sclerosis.

Liguori M, Meier DS, Hildenbrand P, Healy BC, Chitnis T, Baruch NF, Khoury SJ, Weiner HL, Bakshi R, Barkhof F, Guttmann CR.

J Neurol Neurosurg Psychiatry. 2011 Oct;82(10):1125-31. doi: 10.1136/jnnp.2011.242115. Epub 2011 Mar 22.


Reversible neural stem cell niche dysfunction in a model of multiple sclerosis.

Rasmussen S, Imitola J, Ayuso-Sacido A, Wang Y, Starossom SC, Kivisäkk P, Zhu B, Meyer M, Bronson RT, Garcia-Verdugo JM, Khoury SJ.

Ann Neurol. 2011 May;69(5):878-91. doi: 10.1002/ana.22299. Epub 2011 Mar 9.


Multimodal coherent anti-Stokes Raman scattering microscopy reveals microglia-associated myelin and axonal dysfunction in multiple sclerosis-like lesions in mice.

Imitola J, Côté D, Rasmussen S, Xie XS, Liu Y, Chitnis T, Sidman RL, Lin CP, Khoury SJ.

J Biomed Opt. 2011 Feb;16(2):021109. doi: 10.1117/1.3533312.


HLA (A-B-C and -DRB1) alleles and brain MRI changes in multiple sclerosis: a longitudinal study.

Liguori M, Healy BC, Glanz BI, Khoury SJ, Moscufo N, Weiner HL, De Jager PL, Guttmann CR.

Genes Immun. 2011 Apr;12(3):183-90. doi: 10.1038/gene.2010.58. Epub 2010 Dec 23.


Supplemental Content

Loading ...
Support Center